Spectral AI, Inc. (NASDAQ: MDAI) Stock Competitors & Peer Comparison

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, ALC has a market cap of 34.4B. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while ALC trades at $69.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas ALC's P/E ratio is 22.17. In terms of profitability, MDAI's ROE is +1.21%, compared to ALC's ROE of +0.03%. Regarding short-term risk, MDAI is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ALC's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, STE has a market cap of 21.9B. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while STE trades at $219.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas STE's P/E ratio is 21.55. In terms of profitability, MDAI's ROE is +1.21%, compared to STE's ROE of +0.11%. Regarding short-term risk, MDAI is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check STE's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, QDEL has a market cap of 952.6M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while QDEL trades at $13.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas QDEL's P/E ratio is 10.43. In terms of profitability, MDAI's ROE is +1.21%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, MDAI is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check QDEL's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, MLAB has a market cap of 715M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while MLAB trades at $125.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas MLAB's P/E ratio is 12.89. In terms of profitability, MDAI's ROE is +1.21%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, MDAI is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MLAB's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, BWAY has a market cap of 555M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while BWAY trades at $14.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas BWAY's P/E ratio is 35.95. In terms of profitability, MDAI's ROE is +1.21%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, MDAI is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check BWAY's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, SI has a market cap of 421.4M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while SI trades at $19.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas SI's P/E ratio is -10.61. In terms of profitability, MDAI's ROE is +1.21%, compared to SI's ROE of -0.26%. Regarding short-term risk, MDAI is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check SI's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, MASS has a market cap of 412.3M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while MASS trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas MASS's P/E ratio is -16.75. In terms of profitability, MDAI's ROE is +1.21%, compared to MASS's ROE of -0.25%. Regarding short-term risk, MDAI is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MASS's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, MOBI has a market cap of 386.7M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while MOBI trades at $11.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas MOBI's P/E ratio is -0.62. In terms of profitability, MDAI's ROE is +1.21%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, MDAI is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check MOBI's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, ANIK has a market cap of 278.5M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while ANIK trades at $21.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas ANIK's P/E ratio is 42.47. In terms of profitability, MDAI's ROE is +1.21%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, MDAI is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ANIK's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, LAB has a market cap of 268.3M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while LAB trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas LAB's P/E ratio is -9.79. In terms of profitability, MDAI's ROE is +1.21%, compared to LAB's ROE of -0.18%. Regarding short-term risk, MDAI is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check LAB's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, TRIB has a market cap of 190.6M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while TRIB trades at $9.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas TRIB's P/E ratio is -0.16. In terms of profitability, MDAI's ROE is +1.21%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, MDAI is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check TRIB's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while EDAP trades at $4.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas EDAP's P/E ratio is -5.80. In terms of profitability, MDAI's ROE is +1.21%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, MDAI is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check EDAP's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, NYXH has a market cap of 162.1M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while NYXH trades at $1.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas NYXH's P/E ratio is -0.64. In terms of profitability, MDAI's ROE is +1.21%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, MDAI is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check NYXH's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, APYX has a market cap of 128.4M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while APYX trades at $3.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas APYX's P/E ratio is -15.25. In terms of profitability, MDAI's ROE is +1.21%, compared to APYX's ROE of -0.79%. Regarding short-term risk, MDAI is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check APYX's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, SKIN has a market cap of 88.8M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while SKIN trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas SKIN's P/E ratio is -3.11. In terms of profitability, MDAI's ROE is +1.21%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, MDAI is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check SKIN's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, DRIO has a market cap of 52.9M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while DRIO trades at $6.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas DRIO's P/E ratio is -1.24. In terms of profitability, MDAI's ROE is +1.21%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, MDAI is more volatile compared to DRIO. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check DRIO's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, BEAT has a market cap of 23.7M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while BEAT trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas BEAT's P/E ratio is -0.84. In terms of profitability, MDAI's ROE is +1.21%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, MDAI is more volatile compared to BEAT. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check BEAT's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, BEATW has a market cap of 8.4M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while BEATW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas BEATW's P/E ratio is -0.02. In terms of profitability, MDAI's ROE is +1.21%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, MDAI is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check BEATW's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while WOK trades at $2.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas WOK's P/E ratio is N/A. In terms of profitability, MDAI's ROE is +1.21%, compared to WOK's ROE of -0.19%. Regarding short-term risk, MDAI is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check WOK's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while QTEXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, MDAI's ROE is +1.21%, compared to QTEXW's ROE of N/A. Regarding short-term risk, MDAI is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check QTEXW's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, FEED has a market cap of 3.1M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while FEED trades at $4.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas FEED's P/E ratio is -0.03. In terms of profitability, MDAI's ROE is +1.21%, compared to FEED's ROE of -0.60%. Regarding short-term risk, MDAI is more volatile compared to FEED. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check FEED's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, ITOC has a market cap of 3M. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while ITOC trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas ITOC's P/E ratio is -1.03. In terms of profitability, MDAI's ROE is +1.21%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, MDAI is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check ITOC's competition here

Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDAI stands at 50M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, MDAI is priced at $1.62 on the NASDAQ, while TIVC trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDAI currently has a P/E ratio of -3.49, whereas TIVC's P/E ratio is -0.04. In terms of profitability, MDAI's ROE is +1.21%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, MDAI is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check TIVC's competition here